Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. (CMMB): 1 pipeline candidate · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
N/A
D/E 0.12
Lead: Phase 2
1 candidate
N/A
2 buys · 0 sells (180d)
A transparent, data-derived signal for Chemomab Therapeutics Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$11.8M
Cash
$7.6M
Quarterly Burn
—
Runway
—
Revenue
—
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| 10 mg/kg cm-101 | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
13
Total value held
$458K
| Holder | Shares | Value |
|---|---|---|
| adar1 capital management, llc | 80,000 | $126K |
| citadel advisors llc | 64,182 | $101K |
| kestra private wealth services, llc | 61,710 | $97K |
| xtx topco ltd | 18,629 | $29K |
| rhumbline advisers | 18,366 | $29K |
| smartharvest portfolios, llc | 14,566 | $23K |
| susquehanna international group, llp | 13,491 | $21K |
| bnp paribas financial markets | 8,425 | $13K |
| gamma investing llc | 7,579 | $12K |
| morgan stanley | 4,575 | $7K |
Showing top 10 of 13 institutional holders of Chemomab Therapeutics Ltd.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Chemomab Therapeutics Ltd.'s pipeline?
Chemomab Therapeutics Ltd. (CMMB) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is Chemomab Therapeutics Ltd.'s lead drug candidate?
Chemomab Therapeutics Ltd.'s most advanced tracked candidate is 10 mg/kg cm-101 (Phase 2) for Systemic Sclerosis.
What is Chemomab Therapeutics Ltd.'s market capitalization?
Chemomab Therapeutics Ltd.'s market capitalization is approximately $11.8M.
Who is the CEO of Chemomab Therapeutics Ltd.?
Dr. Adi Mor George Ph.D. is the chief executive officer of Chemomab Therapeutics Ltd. (CMMB).
Get the full picture on Chemomab Therapeutics Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.